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Background: Autophagy is an indispensable lysosomal self-digestion process involved in the degradation of
aggregated proteins and damaged organelles. Autophagy is associated with the several pathological processes,
including cancer. Cancer stem cells (CSCs) play significant roles in cancer initiation, progression and drug
resistance. Recent studies have demonstrated the antitumor activities of plant-derived chemopreventive agent
rottlerin (Rott). However, the molecular mechanism by which Rott induces autophagy in breast CSCs has not
been investigated.
Results: The objectives of this study were to examine the molecular mechanism by which Rott induces
autophagy which leads to apoptosis in breast CSCs. Treatment of breast CSCs with Rott for 24 h resulted in a
concentration dependent induction of autophagy, followed by apoptosis as measured by flow cytometry.
Electron microscopy confirmed the presence of autophagosomes in Rott treated breast CSCs. Western blot
analysis showed that Rott treatment increased the expression of LC3, Beclin-1 and Atg12 that are accumulated
during autophagy. Prolonged exposure of breast CSCs to Rott caused apoptosis which was associated with the
suppression of phosphorylated Akt and mTOR, upregulation of phosphorylated AMPK, and downregulation of
anti-apoptosis Bcl-2, Bcl-XL, XIAP and cIAP-1. Knock-down of Atg7 or Beclin-1 by shRNA inhibited Rott-induced
autophagy at 24 h. Our study also demonstrates that pre-treatment of breast CSCs with autophagosome
inhibitors 3-methyladenine and Bafilomycin, as well as protein synthesis inhibitor cycloheximide inhibited Rott-induced
autophagy and apoptosis. Rott induces autophagy via extensive cytoplasmic vacuolization in breast CSCs. Molecular
docking results between C2-domain of protein kinase C-delta and Rott indicated that both hydrogen bonding and
hydrophobic interactions contributed significantly for ligand binding with minimum binding affinity of ≈ 7.5 Kcal/mol.
Although, autophagy inhibitors suppress the formation of cytoplasmic vacuolization and autophagy in breast CSCs, the
potency of Rott to induce autophagy and apoptosis might be based on its capability to activate several pathways such
as AMPK and proteasome inhibition.
Conclusions: A better understanding of the relationship between autophagy and apoptosis would eventually allow us
to discover novel drugs for the treatment of breast cancer by eliminating CSCs.
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Autophagy is a highly conserved cellular process that is
involved in several catabolic processes, cellular develop-
ment [1], autoimmunity [2], degradation of long-lived
proteins and organelles [3], and cell death [4]. It has
also been involved in several other cellular mechanism
which are directly or indirectly related to diseases like
neurodegeneration, cardiovascular, aging and cancer
[5]. Autophagy takes place at basal levels in most of the
cell types but is also regulated developmentally and/or
by environmental stimuli. Autophagy is upregulated
when cells encounter environmental stressors such as
nutrient starvation, pathogen infection and chemother-
apeutic agents, [6-9] and the process is essential for the
maintenance of cellular energy, and thereby, for cell
survival in stress conditions [10,11]. Although autoph-
agy is initiated as a protective response to stress, the
constitutive activation of autophagy can lead to cell
death by excessive self-degradation of essential cellular
components [12].
Recently, it has been reported that the chemotherapeu-
tic agents [13,14] induced the early stage of autophagy in
cancer stem cells (CSCs) [15,16], and it is regulated by sev-
eral ‘Atg’ (Autophagy-related) genes [17] and proteins
which have been implicated in autophagosome formation
[18]. Autophagosome nucleation requires a complex
containing Atg6, whereas elongation of autophagosome
involves Atg12 and Atg8 (LC3 in mammals) [19]. Atg7 is
required to recruit other proteins to the autophagosomal
membrane and to form the autophagic vacuole in a path-
way [20,21]. All together, they form autophagic membrane;
this membrane assembles around damaged organelles,
proteins and cytoplasm. Later, the outer membrane of
autophagosomes is fused by endosomes or lysosomes to
form autolysosomes where lysosomal hydrolases degrade
the cytoplasm derived contents of autophagosome to-
gether with its inner membrane and presented to citric
acid cycle for energy generation [22]. Moreover, an im-
portant autophagy-regulatory gene such as Beclin-1 func-
tions as a haplo-insufficient tumor suppressor gene [23],
further emphasizing the clinical importance of autophagic
cell death and apoptosis.
Despite of these advances, the relationship between au-
tophagy and apoptosis in CSCs is still not well understood.
CSCs may be responsible for tumor onset, self-renewal/
maintenance, mutation accumulation, and metastasis [24].
In CSCs, autophagy plays an important role in the regula-
tion of drug resistance, self-renewal, differentiation, and
tumorigenic potential [25,26], suggesting autophagy could
be a promising therapeutic target in a subset of cancers. In
some circumstances, both autophagy and apoptosis have
been observed in the same cells, [27-30] and they may be
interconnected by some signaling pathway [17,31]. The
Akt/mTOR and AMPK signaling pathway is a keyregulator of physiological cell processes which include
proliferation, differentiation, apoptosis, motility, metabol-
ism, and autophagy. Several anti-apoptotic signals such as
the Akt/mTOR signaling pathway, and Bcl-2 suppress au-
tophagy [17,32] and concurring-apoptotic signals such as
the AMPK signaling pathway, and Bax activate autophagy
[33]. Conversely, autophagy may inhibit apoptosis, [34,35]
and the inhibition of autophagy can activate apoptosis
[28,31,36].
Autophagy also plays an essential role in the maintenance
of cellular energy and for cell survival in stress conditions
[10,11]. Endoplasmic Reticulum (ER) stress and activation
of AMPK are among the major regulators of autophagy
[37], which are involved in biosynthesis, protein folding and
modification of various soluble and insoluble proteins [38].
The ER-resident proteins, PERK and IRE1, and increased
cytosolic calcium have been implicated as mediators of ER
stress induced autophagy in mammalian cells [39]. These
mediators activate autophagy by upregulating Atg12 and
LC3 conversion [40]. ER stress also leads to release of cal-
cium from ER to cytosol, which in turn can activate various
kinases that are involved in autophagy signaling [41,42].
Calcium mediated autophagy is regulated by AMP activated
protein kinase (AMPK), which senses cellular energy status
to maintain homeostasis. It is usually activated when ATP
levels are depleted in the cells. Increase in the cytosolic cal-
cium leads to the activation of Ca2+/calmodulin activating
kinase kinase β (CAMKKβ) which further activates AMPK
[43]. In addition, both AMPK and mTOR regulate autoph-
agy through coordinated phoshphorylation of Ulk1 [44,45].
Thus activating autophagy may abolish the resistance of
CSCs to chemotherapy and could lead to the development
of novel therapeutic approaches for the treatment of vari-
ous cancers.
Rott has been used as a protein kinase C-delta signal-
ing pathway inhibitor [46]. It inhibits cell proliferation
and induces apoptosis through mitochondrial mem-
brane depolarization. Recently, in several human cancer
cells, Rott has been shown to induce a starvation re-
sponse, which is a key regulator of autophagy causing
its induction [47]. We have recently reported the exist-
ence and role of human pancreatic CSCs in autophagy
leading to apoptosis induced by Rott [26,48]. Since
breast cancer contains rare breast CSCs, we sought to
examine the molecular mechanism by which Rott in-
duces autophagy in breast CSCs. Breast cancer is one of
the leading gynecological cancers with high mortality
rates. It is usually detected in late stages with poor prog-
nosis. Here we report that Rott-induced early autophagy is
mainly dependent on the induction of autophagosomes,
conversion of LC3-I to LC3-II, expression of Atg12 and
Beclin-1 and inhibition of Bcl-2, Bcl-xL, XIAP and cIAP-1.
Eventually, Rott induced apoptosis through the inhibition
of Akt/mTOR pathway, and activation of caspases and
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Beclin-1 enhanced apoptosis-inducing potential of Rott.
These findings strongly suggest that Rott-induced au-
tophagy may play some important role in induction of
apoptosis. For the first time we report that Rott acti-
vates autophagy by inducing the phosphorylation of
AMPK. We show a novel function of Rott that is in-
volved in inducing early autophagy and late apoptosis in
breast CSCs.
Results
Rottlerin induced cytoplasmic vacuolation and cell death
in breast CSCs
To examine whether Rott induces cytotoxic effect on
breast CSCs, we treated breast CSCs with different concen-
trations of Rott (0, 0.5, 1 and 2 μM) for various time pointsFigure 1 Rottlerin inhibited cell viability, and induced apoptosis and
complete stem cell culture medium and treated with Rott (0, 0.5, 1 and 2 μ
Blue color (12 h), red (24 h), green (48 h), and violet (72 h). (b) Breast CSCs
autophagic vacuoles were counted under phase contrast microscope. (c) B
(10 mM) or CHX (10 μg/ml) for 48 h, and the autophagic vacuoles were co
in complete stem cell culture medium and treated with the different conce
were obtained by phase contrast microscopy. Magnification, 20X. Red arrow
concentration of Rott (0, 0.5, 1 and 2 μM). (e) Breast CSCs were cultured in
and Baf (10 nM), 3-MA (10 mM) or CHX (10 μg/ml) for 48 h. Representative
20X. Red arrows indicate cytoplasmic vacuoles. Data are reported as the m
compared with Rott treated in an identical manner.(12, 24, 48 and 72 h). Rott inhibited cell viability in a time-
and dose-dependent manner (Figure 1a). While the treat-
ment with 0.5 μM Rott had little effect on cell viability,
treatments with 1 or 2 μM Rott for 48 and 72 h signifi-
cantly inhibited cell viability. We next measured cytoplas-
mic vacuolation induced by Rott (Figure 1b and d). Rott
induced autophagy in breast CSCs by forming cytoplasmic
vacuolation in a dose-dependent manner. 1 μM and 2 μM
Rott induced more cytoplasmic vacuolatyion in breast
CSCs compared to 0.5 μM (Figure 1b and d). Whereas, co-
treated breast CSCs with Rott and Baf, 3-MA or CHX
inhibited cytoplasmic vacuolation (Figure 1c and e). More-
over, the breast CSCs treated with Rott showed morpho-
logical features of cytoplasmic vacuole accumulation. Rott
increased more numbers of vacuole formation in the cyto-
plasm of breast CSCs (Figure 1d).cytoplasmic vacuolation in breast CSCs. (a) Cells were grown in
M) for different time points. Cell viability was measured by XTT assay.
were treated with Rott (0, 0.5, 1 and 2 μM) for 48 h, and the
reast CSCs were co-treated with Rott (2 μM) and Baf (10 nM), 3-MA
unted under phase contrast microscope. (d) Breast CSCs were cultured
ntrations of Rott (0, 0.5, 1 and 2 μM) for 48 h. Representative images
s indicate cytoplasmic vacuoles developed by the effect of different
complete stem cell culture medium and co-treated with Rott (2 μM)
images were obtained by phase contrast microscopy. Magnification,
ean ± standard error (SE) of percentage of cells. n = 5, *P < 0 · 05 when
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LC3 is a hallmark of autophagy and the conversion of LC3-
I to LC3-II via proteolytic cleavage and lipidation shows
autophagy induction. Therefore, to study whether Rott in-
duced autophagy in breast CSCs, the formation of LC3
punctate dots and conversion of LC3-I to LC3-II were ex-
amined by different molecular technique. This modification
of LC3 is essential for the formation of autophagosomes
and for the completion of macroautophagy. To confirm
whether LC3 (autophagosomes) is redistributed after RottFigure 2 Autophagic cell-death by rottlerin in breast CSCs. (a) Redistri
pEGFP-LC3 fusion construct and cultured in complete stem cell culture mediu
visualized under a fluorescence microscope to examine the expression of LC3
CSCs. (b) Electron microscopy shows the ultrastructure of breast CSCs treated
culture medium for 48 h. Arrows indicate autophagosomes including residual
pEGFP-LC3-positive breast CSCs treated with Rott (0, 0.5, 1 and 2 μM) for 48 h
dot in pEGFP-LC3-positive cells. Quantification represents at least 100 cells cou
in pEGFP-LC3-positive breast CSCs co-treated with Rott (2 μM) and Baf (10 nM
dot per cell based on number of punctuate dot in pEGFP-LC3-positive cells. Q
treatment. Data are reported as the mean ± standard error (SE) of percentage
identical manner.treatment, we observed the induction of LC3 punctate
dots in LC3 transfected breast CSCs with the exposure
of different concentration of Rott (Figure 2a). Cells were
cultured in complete stem cell culture medium, treated
with or without Rott and subjected to immunofluores-
cence for visualization of pEGFP-LC3 transfected cells.
Our results indicated that Rott induced autophagy in a
dose dependent manner (Figure 2a). To examine whether
cell vacuolation induced by Rott is related to autophagy,
breast CSCs were treated with Rott (0, 0.5, 1 and 2 μM)bution of pEGFP-LC3. Breast CSCs were stably transfected with a
m, and treated with Rott (0, 0.5, 1 and 2 μM) for 48 h. Cells were
-II. LC3 expression increases by increasing Rott concentration in breast
with different concentrations of Rott (0 and 2 μM) in complete stem cell
digested material (red arrow). (c) Punctate dot quantification in
. Quantification of puncatate dot per cell based on number of punctuate
nted and scored per treatment. (d, e and f) Punctate dot quantification
), 3-MA (10 mM) or CHX (10 μg/ml) for 48 h. Quantification of puncatate
uantification represents at least 100 cells counted and scored per
of cells. n = 5, *P < 0 · 05 when compared with Rott treated in an
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electron microscopy. Numerous autophagic vacuoles con-
taining lamellar structures or residual digested material
and empty vacuoles were observed in the breast CSCs
when treated with 2 μM of Rott, indicating that Rott not
only increased the number of vacuoles, but also increased
the number of mature autophagosomes formed per cell
(Figure 2b). We next counted and graded CSCs based on
abundance of LC3-II positive staining. The number of
LC3-II positive CSCs and severity of autophagic response
per cell (number of autophagosomes present per cell) was
increased following Rott treatment at 48 h (Figure 2c).
However the co-treated breast CSCs with Rott and au-
tophagy inhibitors Baf, 3-MA or CHX inhibited autophagy
(Figure 2d, e and f). 3-MA is a phosphatidylinositol 3-
kinase class-III enzyme inhibitor which is essential for the
autophagic process and the autophagy inducing potential of
Rott was partially reverted with 3-MA, indicating that in-
hibition of phosphatidylinositol 3-kinase class III enzyme
reduced the number of cells undergoing autophagy. Baf is a
potent and specific inhibitor of vacuolar H +ATPase (V-
ATPase) which stops the acidification of lysosomes during
the formation of autophagosomes and slows down the lipi-
dation of LC3 protein. CHX, a small molecule inhibitor of
protein synthesis, blocks the elongation phase of eukaryotic
translation.
Molecular evidence of regulation of autophagy by rottlerin
To determine whether Rott regulates autophagy at 24–
48 h, first we examined the levels of LC3-II, which is an
LC3-phosphatidylethanolamine conjugate and a promising
autophagosomal marker. Rott induced an increase in the
lipidated form of LC3 (LC3-II) at 24–48 h, further indicat-
ing the induction of autophagy at early stage (Figure 3a).
However, Rott-induced conversion of LC3-I to LC3-II was
not observed at 72 h. We next measured the expression
of autophagy-related proteins, LC3, Atg12, Beclin-1 in
breast CSCs treated with Rott (Figure 3b). The levels of
Atg12 and Beclin-1 expression were increased in a dose
dependent manner following treatment with Rott. These
results indicate that Rott stimulated not only the conver-
sion of a fraction of LC3-I into LC3-II but also caused the
accumulation of Atg12 and Beclin-1 proteins. The cellular
levels of Bcl-2, Bcl-xL, XIAP and cIAP-1 proteins were sig-
nificantly decreased after the treatments with Rott for 48 h
(Figure 4a). The accumulation of Atg12 and Beclin-1 pro-
teins may be mediated by the reduction in Bcl-2 and Bcl-xL
expression. To assess how the pro-apoptotic effect of Rott
was linked to the autophagies signal, we used autophagy in-
hibitors (Baf and 3-MA), and protein synthesis inhibitor
(CHX). Treatment of breast CSCs with Baf, 3-MA or CHX
inhibited Rott-induced conversion of LC3, and induction of
Atg12 and Beclin-1 (Figure 3c, d and e), suggesting that
Rott has potential to induce autophagy in CSCs.Inhibition of Atg7 or Beclin-1 by shRNA suppressed
Rott-induced autophagy in breast CSCs. We have recently
demonstrated the requirement of Atg7 or Beclin-1 in
Rott-induced autophagy [25,26]. To investigate the mech-
anism of Rott-induced autophagy in breast CSCs, we
inhibited autophagy by Atg7 shRNA or Beclin-1 shRNA.
These plasmids have been previously validated in our
laboratory [25,26]. As shown in (Figure 3f), overexpression
of either Atg7 shRNA or Beclin-1 shRNA suppressed
Rott-induced autophagy, suggesting the requirement of
these genes in Rott-induced autophagy.
Rottlerin-induced autophagy is mediated via activation of
AMPK pathway
Several recent studies have shown that activation of
AMPK is important in regulating autophagy. We wanted
to test whether this was the case in our model. The
western blot data showed that Rott activated AMPK by
phosphorylating it at Thr-172 in breast CSCs. Further,
to confirm the role of AMPK in Rott induced autoph-
agy, we exposed the CSCs to Baf, 3-MA or CHX before
treating with Rott. Treatment of breast CSCs with Baf, 3-
MA, and CHX inhibited Rott-induced activation of AMPK
(Figure 3c, d and e). Interestingly, blocking AMPK activa-
tion also blocked the expression of LC3, Atg12 and Beclin-
1 in breast CSCs, indicating that AMPK also mediates the
effect of Rott on autophagy. These results strongly establish
that AMPK is a major regulator of Rott-induced autophagy
in breast CSCs.
Rottlerin induced apoptotic cell death via inhibition of
Akt/mTOR pathway and activation of caspases
Akt/mTOR signaling pathway is involved in the regula-
tion of cell cycle, cellular transformation, cell growth,
and tumorigenesis. To investigate the upstream inhib-
ition of mTOR by Rott, we examined Ser473 phosphor-
ylation of Akt. As shown in (Figure 4b), treatment with
Rott decreased the levels of phosphorylated Akt and
mTOR in breast CSCs. These data suggest that Rott in-
duces apoptosis by inhibiting Akt/mTOR pathway. To
gain further insight into the mechanism by which Rott
induces cell death, we examined the effects of Rott on
the expression of apoptosis-related proteins (Figure 4a
and b). Treatment of breast CSCs with Rott resulted in
cleavage of caspase-3 and caspase-9. Furthermore, the
levels of IAP family proteins, such as XIAP and cIAP-1,
which bind to caspases and lead to their inactivation,
were downregulated by Rott treatment (Figure 4a).
Moreover, the cellular levels of anti-apoptotic Bcl-2 and
Bcl-xL proteins were significantly decreased, whereas
pro-apoptotic Bax level was increased in response to
Rott, indicating Rott induced cell death in CSCs due to
an increase in the relative ratio of Bax/Bcl-2 (and/or
Bcl-xL) expression.
Figure 3 Rottlerin induced autophagy in breast CSCs. (a) Breast CSCs were grown in complete stem cell culture medium and treated with
Rott (2 μM) for 0, 24, 48 and 72 h. Representative blots showing the concentration dependent effect of Rott on breast CSCs. Rott regulates
autophagy-related genes in breast CSCs. Conversion from LC3-I to LC3-II by Rott. The Western blot analysis was performed to measure the
expression of LC3. β-actin was used as a loading control. (b) Breast CSCs were grown in complete stem cell culture medium and treated with Rott
(0, 0.5, 1 and 2 μM) for 48 h. The Western blot analysis was performed to measure the expression of Atg12, Beclin-1, LC3 and β-actin. (c) Breast
CSCs were pre-incubated with Baf (10 nM) for 2 h, followed by treatment with Rott (2 μM) in complete stem cell culture medium for 48 h. The
Western blot analysis was performed to measure the expression of p-AMPK, AMPK, Atg12, Beclin-1, LC3 and β-actin. (d) Breast CSCs were
pre-incubated with CHX (10 μg/ml) for 2 h, followed by treatment with Rott (2 μM) for 48 h. The Western blot analysis was performed to measure
the expression of p-AMPK, AMPK, Atg12, Beclin-1, LC3 and β-actin. (e) Breast CSCs were pre-incubated with 3-MA (10 mM) for 2 h, followed by
treatment with Rott (2 μM) for 48 h. The Western blot analysis was performed to measure the expression of p-AMPK, AMPK, Atg12, Beclin-1, LC3
and β-actin. (f) Atg7 or Beclin-1 shRNA inhibits Rott-induced autophagy. pEGFP-LC3-positive breast CSCs were transduced with scrambled, Atg7
shRNA or Beclin-1 shRNA and treated with Rott (2 μM) for 24–48 h. Autophagy was measured as described in Figure 2. Data are reported as the
mean ± standard error (SE). n = 5, *P < 0.05.
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We studied the effect of Rott on the induction of autophagy
leads to the apoptotic cell death in breast CSCs by using
C6-flow cytometer. Rott did not significantly induce apop-
tosis in breast CSCs at 24 and 48 h (data not shown), but
significantly induced apoptotic cell death at 72 h (Figure 5a
to e). Breast CSCs treated with different concentration of
Rott (0, 0.5, 1 and 2 μM) underwent apoptosis as assessed
by flowcytomer using propidium iodide (PI), and annexin-
V/PI staining (Figure 5a, b, c, d and e). Cells underwent
apoptosis quickly showed an increase in annexin-V binding
by increasing Rott concentration but excluded PI (early
apoptosis). At later time-points, the percentage of PI-
staining of breast CSCs gradually increased (late apoptosis).
Therefore, we report here both the percentage of earlyapoptosis (which indicates annexin-V-positive cells only)
and the percentage cell death, which indicates the total
number of annexin-V-FITC-plus PI staining cells and is
representative of populations containing cells at both early
and late stages of apoptosis.
Further, to confirm the role of Baf, 3-MA or CHX in
apoptotic cell death, we exposed breast CSCs to Baf, 3-
MA or CHX before treating with Rott. Rott-induced
apoptosis in breast CSCs, as assessed by PI (Figure 6a,
b, c and d) and annexin-V/PI (Figure 7a, b, c, d and e)
staining through flow cytometry. Pretreatment of CSCs
with Baf, 3-MA or CHX inhibited Rott induced apop-
tosis. These data suggest that inhibition of autophago-
some and protein synthesis can block Rott-induced
apoptosis.
Figure 4 Rottlerin induced apoptosis in breast CSCs. (a) Breast
CSCs were grown in complete stem cell culture medium and
treated with Rott (0, 0.5, 1 and 2 μM) for 48 h. The Western blot
analysis was performed to measure the expression of Bax, Bcl-2,
Bcl-xL, XIAP, cIAP-1, and β-actin. (b) Breast CSCs were grown in
complete stem cell culture medium and treated with Rott (0, 0.5, 1
and 2 μM) for 48 h. The Western blot analysis was performed to
measure the expression of active caspase-3, active caspase-9,
p-AMPK, AMPK, p-Akt, Akt, p-mTOR, mTOR and β-actin.
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C-delta and rottlerin
Molecular docking is a computational method that at-
tempts to predict noncovalent binding between macro-
molecule (receptor/protein) and a small molecule (ligand).
In order to understand the induction of autophagy in
CSCs in exposure to Rott we have performed molecular
docking between protein kinase C-delta inhibitor (Rott)
[46] and C2-domain of protein kinase C-delta [49]. We
have used AutoDock-Vina [50] docking program to see
the interaction between protein and ligand. There are sev-
eral other docking programs (e.g. GOLD, FleX, FRED)
which can be used to predict the binding affinity between
protein and ligand. AutoDock-Vina showed best for carry-
ing out blind docking between protein and ligand among
them [51]. Each docking result generated top ten best
binding conformations of the ligand and the best binding
poses (Figure 8). The 3D view of protein–ligand interac-
tions of the best poses generated by ADT are shown in
Figure 8. As clearly showed in Figure 8, an important in-
teractions can be found between ligand and the residues
SER8, ASN10, THR58, GLU83, PRO80, VAL84, THR85,
GLN109, CYS117 and GLN119 which directly participate
in the catalytic mechanism of this protein. The protein-
ligand complex is stabilized mainly by hydrogen bonds
and hydrophobic interactions. All the top docked poses
generated by each docking routine exhibited well-
established bonds with one or more amino acids in the
binding pocket of C2-domain of protein kinase C-delta.
The top-ranked pose with lowest docked binding affin-
ities and high docking scores is generally used as a
standard selection in most of the docking programs.
The best poses of C2-domain of protein kinase C-delta-Rott were generated by AutoDock-Vina. The binding af-
finity for Rott was found to be −7.5 Kcal/mol. The orienta-
tion and hydrogen bonding, ionic interactions of Rott with
C2-domain of protein kinase C-delta active site are shown
in Figure 8. These docking experiments suggest that Rott
can directly bind to protein kinase C-delta.
Discussion
In this study we demonstrated that Rott induces early
autophagy as a survival strategy against late apoptosis
through AMPK and Akt/mTOR cascade dependent path-
ways in human breast CSCs. One of the most surprising
events in the early stage apoptosis by Rott treatment was
the cytoplasmic vacuolation. These vacuoles were formed
by Rott-induced autophagy and were identified by electron
microscopy, acidic vesicular organelle staining, and trans-
fection of green fluorescent protein-LC3. Interestingly,
Rott-treated cells did not undergo cell death at 24 h, while
at late time points (72 h) showed significant cell death.
Rott induced autophagy at 24–48 h, as evident by forma-
tion of autophagosomes and conversion of LC3-I to LC3-II
form. Rott was found to cause typical autophagy character-
istics, including formation of autophagosomes and acidic
vacuoles, and redistribution of LC3 at 24–48 h. These re-
sults indicate that treatment with Rott may induce autoph-
agy at an early stage in breast CSCs. Our study for the first
time demonstrates that Rott treatment induces autophagy
in breast CSCs by activating AMPK pathway.
Autophagy is a catabolic process during which damaged
organelles and proteins are engulfed and degraded to pro-
vide metabolic needs. Autophagy is activated in response to
various kinds of stress. It is a conserved dynamic process in
which intracellular membrane structures sequester proteins
and organelles, which are finally delivered to lysosomes for
bulk degradation and ATP generation to maintain basal cel-
lular bioenergetics [17]. Whereas the above situations envi-
sion autophagy as a survival mechanism, autophagy can
also lead to cell death under some circumstances [52].
Rott-induced apoptotic cell death was mediated through
a decrease of mitochondrial membrane potential and
translocation of AIF into nucleus at a late time point.
Moreover, the inhibition of Rott-induced autophagy with
Baf, 3-MA or CHX slows down apoptotic cell death. The
most novel mechanistic aspect of this study is, perhaps,
that Rott-induced autophagy may act as a survival factor
against caspase-independent cell death. Treatment with
Rott induced a dose- and time-dependent growth inhib-
ition and also triggered cell death with cytoplasmic
vacuolation in breast CSCs, which is consistent with the
reported biological events caused by Rott in breast tumor
and malignant glioma cells [53,54]. On the other hand,
Rott treatment in the presence of Baf, 3-MA or CHX lead
to decreased expression of LC3 when compared to the cells
treated either with Rott or inhibitors alone, suggesting
Figure 5 Apoptotic cell-death measured by flow cytometer in breast CSCs. (a) Breast CSCs were treated with Rott (0, 0.5, 1 and 2 μM) in
complete stem cell culture medium for 48 h and apoptosis was measured by PI staining followed by flow cytometry. Data are the means of
triplicate experiments. (b) Time-course evaluation of spontaneous apoptosis of breast CSCs treated with Rott (0, 0.5, 1 and 2 μM) in complete
stem cell culture medium for 48 h and apoptosis was measured by annexin-V/PI staining followed by flow cytometry. Data are the means of
triplicate experiments. Representative histograms are shown of Rott treated breast CSCs stained with annexin-V and propidium iodide. After 48 h
of culture, three populations of cells were observed: viable cells (negatively stained, lower left quadrants); early apoptotic cells (annexin-V positive
and propidium iodide negative, lower right quadrant) and cells in the late stages of apoptosis (annexin-V and propidium iodide positive, upper
right quadrants). By increasing Rott concentration at 48 h, a greater number of breast CSCs underwent the early and late stages of apoptosis. (c)
Kinetic evaluation of cells undergoing the early stage of apoptosis in breast CSCs. Cells staining with annexin-V only, showing the early stage of
apoptosis (% early apoptosis) (d) Kinetic evaluation of cells underwent the late stage of apoptosis in breast CSCs. Cells staining with annexin-V
alone and with both annexin-V and propidium iodide were combined, giving the total number of cells at both the early and late stages of
apoptosis (% cell death). (e) Kinetic evaluation of cells underwent apoptotic cell death in breast CSCs. Data are reported as the mean ± standard
error (SE) of percentage of cells. n = 5, *P < 0.05 when compared with Rott treated in an identical manner.
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and CHX inhibit the fusion between autophagosomes
and lysosomes, thus prevent the execution step of au-
tophagy. Nonetheless, our results from flowcytometry
demonstrated that autophagy inhibitors (Baf and 3-
MA), and protein synthesis inhibitor (CHX) inhibits
Rott-induced autophagy. Our observations are in agree-
ment with several studies demonstrating the role of LC3
in autophagy [33,55,56].In this study, Rott was found to induce autophagy in
breast CSCs, including formation of autophagosomes,
redistribution of LC3 and induction of autophagy re-
lated proteins including Atg12 and Beclin-1 at 24–48 h.
The antiapoptotic protein, Bcl-2, inhibits the Beclin-1
dependent autophagy [57,58]. Rott significantly inhib-
ited Bcl-2 and Bcl-xL expression, and induced Atg12
and Beclin-1. Furthermore, Baf, 3-MA or CHX inhibited
Rott-induced conversion of LC3-I to LC3-II, and
Figure 6 Apoptotic cell-death measured by PI staining in breast CSCs. Cells were co-treated with Rott (2 μM) and Baf (10 nM), 3-MA
(10 mM) or CHX (10 μg/ml). (a) Rott (2 μM) and Baf (10 nM), (b) Rott (2 μM) and CHX (10 μg/ml), and (c) Rott (2 μM) and 3-MA (10 mM) in
complete stem cell culture medium for 48 h. Apoptosis was measured by PI staining followed by flow cytometry. Data are the means of triplicate
experiments. (d) Kinetic evaluation of cells underwent apoptotic cell death in breast CSCs. Data are reported as the mean ± standard error (SE) of
percentage of cells. n = 5, *P < 0.05 when compared with Rott treated in an identical manner.
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http://www.molecular-cancer.com/content/12/1/171expression of autophagy-related proteins Atg12 and
Beclin-1 at 24–48 h. Activation of autophagy by Rott in
our model was confirmed by enhanced expression of
LC3. Our results also showed that autophagy induction
was associated with an increase in the expression of
Beclin-1 and Atg12. Autophagy marker LC3 is a protein
that is selectively incorporated into autophagosome bydirectly binding to LC3 and hence aggregate during au-
tophagy. Atg12 is instrumental in the autophagic vesicle
biogenesis [19]. These results indicate that Rott induces
autophagy at an early stage in breast CSCs. Beclin-1 was
originally discovered as a Bcl-2 interacting protein and
was one of the first human proteins shown to be indis-
pensable for autophagy [59]. Another autophagic gene
Figure 7 Apoptotic cell-death measured by annexin-V/PI staining in breast CSCs. Cells were co-treated with Rott (2 μM) and Baf (10 nM),
3-MA (10 mM) or CHX (10 μg/ml) (a) Rott (2 μM) and Baf (10 nM), (b) Rott (2 μM) and CHX (10 μg/ml), and (c) Rott (2 μM) and 3-MA (10 mM) in
complete stem cell culture medium for 48 h. Apoptosis was measured by annexin-V/PI staining followed by flow cytometry. Data are the means
of triplicate experiments. Representative histograms are shown of co-treated with (a) Rott (2 μM) and Baf (10 nM), (b) Rott (2 μM) and CHX
(10 μg/ml), and (c) Rott (2 μM) and 3-MA (10 mM) breast CSCs stained with annexin-V and propidium iodide. After 48 h of culture, three populations
of cells were observed: viable cells (negatively stained, lower left quadrants); early apoptotic cells (annexin-V positive and propidium iodide negative,
lower right quadrant) and cells in the late stages of apoptosis (annexin-V and propidium iodide positive, upper right quadrants). By increasing Rott
concentration at 48 h, a greater number of breast CSCs underwent the early and late stages of apoptosis. (d) Kinetic evaluation of cells undergoing the
early stage of apoptosis in breast CSCs. Cells staining with annexin-V only, showing the early stage of apoptosis (% early apoptosis) (e) Kinetic
evaluation of cells undergoing the early stage of apoptosis in breast CSCs. Cells staining with annexin-V alone and with both annexin-V and propidium
iodide were combined, giving the total number of cells at both the early and late stages of apoptosis (% cell death). Data are reported as the mean ±
standard error (SE) of percentage of cells. n = 5, *P < 0.05 when compared with Rott treated in an identical manner.
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http://www.molecular-cancer.com/content/12/1/171Atg7 is responsible for autophagosome biogenesis [60].
Both genes are monoallelically deleted in 50–75% of
cases of human sporadic breast, ovarian and prostate
cancers [60]. Our study demonstrates that co-treatment
of the CSCs with Rott and Baf, 3-MA or CHX inhibited
the Rott-induced autophagy and slows down the apop-
totic process. Therefore, Rott-induced autophagy mayplay some role in apoptotic cell death. Apoptosis is an
important tumor suppressor mechanism that is blocked
in the majority of human cancers, due to the over acti-
vation of the AMPK and Akt/mTOR pathway [47]. Acti-
vation of AMPK and Akt/mTOR pathway regulates
transcription factors which modulate distinct sets of
genes involved in cell cycle, apoptosis, oxidative stress
Figure 8 Molecular docking between C2-domain of protein kinase C-delta and rottlerin. Binding conformations of top ranked docked
poses of Rott into C2 domain of protein kinase C-delta. Binding activity of docked structure predicted by AutoDock-Vina is only showing
important residues are displayed in CPK style. The inhibitors, and part of the amino acid residues in the background were visualized in New
Ribbon style using the AutoDockTools4.
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http://www.molecular-cancer.com/content/12/1/171and DNA repair [47]. Treatment of CSCs with Rott in-
creased the levels of phosphorylated AMPK. Furthermore,
downregulation of constitutively active Akt/mTOR and up-
regulation of AMPK rendered breast CSCs sensitive to
Rott. Rott induced significant apoptosis in breast CSCs at
48 h by inhibiting phosphorylation of Akt and mTOR, and
expression of Bcl-2, Bcl-xL, cIAP1 and XIAP, up-regulation
of AMPK and Bax, and activation of caspase-3 and −9. Our
results indicate that Rott causes early autophagy and late
apoptosis through inhibition of Akt/mTOR pathway in hu-
man breast CSCs.
The recent study also suggests that autophagy at early
stage may act as a survival mechanism against late apop-
tosis. Thus, inhibition of autophagy by the potent drugs or
genetic means (e.g. inhibiting the expression of Atg7 and
Beclin-1) may enhance the apoptosis-inducing potential of
Rott in highly therapy-resistant human breast CSCs. Our
study established that autophagy induced by Rott treat-
ment was mediated by activation of AMPK pathway.
Chemical inhibitors such as Baf, 3-MA or CHX not only
blocked the induction of LC3, but also inhibited Rottinduced expression of Atg12 in breast CSCs. Rott treat-
ment raises cytosolic calcium levels which activate the
various kinases including AMPK which is known to regu-
late autophagy. AMPK is also an energy sensor and is acti-
vated when there is increase in AMP/ ATP ratio, which is
usually the scenario during cellular stress, the same reason
for which autophagy is activated [33]. In agreement with
these facts, Rott treatment activated AMPK in breast
CSCs. Baf, 3-MA or CHX not only suppressed Rott in-
duced phosphorylation of AMPK but also attenuated the
expression of LC3 and Atg12. All these observations are
in agreement with several studies showing that activation
of AMPK leads to autophagy [33,45,61].
There are several previous studies has been confirmed
that Rott acts as a very effective protein kinase C-delta in-
hibitor and it plays an essential role in the induction of au-
tophagy and apoptotic cell death [15,46]. Apart from
studying the effect of Rott on CSCs and the induction of
autophagy and apoptotic cell death, we have also studied
the computational docking between Rott and C2-domain
of protein kinase C-delta. The docking results between
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http://www.molecular-cancer.com/content/12/1/171Rott and C2-domain of protein kinase C-delta generated by
AutoDock-Vina showed the strong molecular interactions
between Rott and C2-domain of protein kinase C-delta. It
forms hydrogen bonds, hydrophobic and ionic interactions
with the important residues of the binding pocket of C2-
domain of protein kinase C-delta thus stabilizing the struc-
ture of target receptor.
Conclusions
In the present study, for the first time we conclude that
Rott, a natural compound derived from the plant kamala
tree (Mallotus philippinensis) with cytotoxic effect, could
induce extensive cytoplasmic vacuolization in breast CSCs.
The fact that autophagy inhibitors suppress the formation
of cytoplasmic vacuolization confirmed that there might be
interaction between autophagy and apoptosis induced by
Rott. Therefore, Rott could affect the functions of a variety
of proteins and act as a multi-target compound. The po-
tency of Rott to induce autophagy and apoptosis at the
same dose might be based on its capability to activate sev-
eral pathways such as AMPK and proteasome inhibition.
Further studies are needed to elucidate the complicated
signal cascades induced by Rott.
Methods
Cell culture, reagents and antibodies
Human breast CSCs [CD44(+)/CD24(−/low)] were iso-
lated from primary tumors and grown in M171 medium
(Invitrogen, Carlsbad, CA) containing mammary epithelial
growth supplement (MEGS) (Invitrogen, Carlsbad, CA)
and 1% antibiotic-antimycotic (Invitrogen), and main-
tained in a humidified incubator with 5% CO2, and 37°C
temperature. Rott, 3-MA, CHX, Baf, puromycin were
obtained from Sigma-Aldrich Corp. (St. Louis, MO). Anti-
human LC3, Atg7, Atg12, Beclin-1, Bax, Bcl-2, Bcl-XL,
cIAP-1, Akt, pAkt, mTOR, p-mTOR and XIAP, AMPK,
pAMPK and β-actin antibodies were obtained from Cell
Signaling Technology (Danvers, MA).
pEGFP-LC3 transfection in breast CSCs
Breast CSCs were transfected with pEGFP-LC3 plasmid
using neon electroporator at 1400 V, 2-pulses for 20 ms.
30 μg of DNA was mixed with the cell suspension and
electroporated by using 100 μl neon tips. After electropor-
ation, pEGFP-LC3 transfected breast CSCs were seeded in
60 mm culture dish. After 2 days, transfected cells were
selected by 10 μM neomycin, and visualized under Leica
6000B microscope with 10X objectives.
Lentiviral particle production and Atg7 and
Beclin-1 transduction
Atg7 shRNA and Beclin-1 shRNA were obtained from
Open Biosystems (Lafayette, CO). Lentivirus particles
were produced by triple transfection of HEK 293 T cells.Packaging 293 T cells were plated in 10 cm plates at a cell
density of 5 × 106. Transfection of packaging cells and in-
fection of breast CSCs were carried out using standard pro-
tocols with some modifications. In brief, 293 T cells were
transfected with 8 mg of plasmid and 4 mg of lentiviral vec-
tor using lipid transfection (Lipofectamine-2000) according
to the manufacturer’s protocol. Viral supernatants were col-
lected and concentrated by adding PEG-it virus precipita-
tion solution (SBI System Biosciences, Mountain View,
CA). Breast CSCs were transduced with viral particles ex-
pressing scrambled, Atg7 shRNA or Beclin-1 shRNA.
Vacuolated cell enumeration
Cells were seeded in 6-well plates at a density of 1 × 104
cells/well in complete stem cell culture medium and incu-
bated overnight. Cells were then treated with various con-
centration of Rott (0, 0.5, 1 and 2 μM) for 48 h. Vacuolated
cells were counted using fluorescent microscope in at least
100 cells for each condition.
Immunofluorescence assay
Cells were grown on fibronectin-coated coverslips (Beckton
Dickinson, Bedford, MA), and treated with Rott (0, 0.5, 1
and 2 μM), washed in PBS, and fixed for 15 min in 4%
paraformaldehyde. Cells were permeabilized in 0.1% Triton
X-100, washed and blocked in 10% normal goat serum.
After blocking, cells were incubated with primary antibody
(1:100) for overnight at 4°C, washed with PBS and incu-
bated with fluorescently labeled secondary antibody (1:200)
along with 4, 6-diamido-2-phenylindole hydrochloride
(DAPI) (1 mg/ml) for 1 h at room temperature. Finally,
coverslips were washed and mounted using vectashield
(Vector Laboratories, Burlington, CA). Isotype-specific
negative controls were included with each staining. Stained
cells were mounted and visualized under Leica 6000B
microscope with 100X objectives. The number of cells ex-
pressing punctate and the number of punctate per cell were
counted manually.
Nuclear staining with DAPI
After Rott treatment, adherent cells were fixed for 20 min
at room temperature with 4% paraformaldehyde and per-
meablized for 10 min with 0.2% Triton X-100 in PBS.
After PBS washes, cells were stained with 4, 6-diamido-2-
phenylindole hydrochloride (DAPI) in PBS at the concen-
tration of 1 mg/ml for 15 min at room temperature. Cells
were then washed with PBS and visualized using Leica
6000B microscope with 100X objectives.
XTT based cell viability assay
Breast CSCs (1 × 104 in 200 μl culture medium per well)
were seeded in 96-well plate (flat bottom), treated with Rott
(0, 0.5, 1 and 2 μM), and incubated for 48 h at 37°C with
5% CO2. Before the end of the experiment, 50 μl XTT
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dium 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide inner salt) and 25 μM PMS
(phenazine methosulphate) per well was added and plates
were incubated for further 4 h at 37°C and 5% CO2.
The spectrophotometric absorbance of the sample was
measured using a microtitre plate (ELISA) reader. The
wavelength to measure absorbance of the formazon
product was 450 nm, and the reference wavelength was
650 nm.
Measurement of apoptotic cell death by flow cytometer
Breast CSCs (10000 cells/well) were seeded in 6 well plate
and exposed to Rott (0, 0.5, 1 and 2 μM). Cells were then
washed in PBS and collected by trypsinization, and fixed
overnight in 70% glacial ethanol. Next day cells were
washed in PBS and resuspended in 1 mL of PBS containing
50 μg/mL RNase and incubated at 37°C for 2 h. 50 μg/mL
propidium iodide (PI) added in resuspended cells and then
incubated for 60 min in dark at 4°C. Cell cycle analysis was
performed by flow cytometry (Becton Dickinson, Franklin
Lakes, NJ, USA), and the population of cells in each phase
was calculated using the Cell Quest software program. Each
experiment was conducted three times.
Breast CSCs (10000 cells/well) were seeded in 6-well
plates and exposed to Rott (0, 0.5, 1 and 2 μM). Treated
cells were washed twice with cold PBS and resuspended
in buffer at a concentration of 106 cells per ml. Cells
were mixed with 10 μl of fluoresceine isothiocyanate
(FITC)-conjugated annexin-V reagent and 10 μl of
3 mM propidium iodide (PI). After 15 min incubation at
room temperature in the dark and further washings,
samples were analyzed by flow cytometry. Flow cytome-
try was performed with a FACScan analyzer (Becton
Dickinson, Franklin Lakes, NJ, USA) with15 mW argon
ion laser (488 nm) and Cell Quest software. Annexin-V
staining was detected in the FL1 channel, whereas PI
staining was monitored in the FL2 channel: appropriate
quadrants were set and the percentage of cells negative
for stains (viable cells), positive for annexin-V (apoptotic
cells) and positive for PI (dead cells) were acquired.
Electron microscopy
To demonstrate the induction of autophagy in Rott-
treated breast CSCs, cells were treated with (0, 0.5, 1
and 2 μM) of Rott for 24 h; cells were harvested by tryp-
sinization, washed and fixed in 2% glutaraldehyde in
0.1 M phosphate buffer, then post-fixed in 1% osmium
tetroxide buffer. After dehydration in a graded series of
ethanol, cells were embedded in spur resin. Thin sec-
tions (60 nm) were cut on an Ultramicrotome. The sec-
tioned grids were stained with saturated solutions of
uranyl acetate and lead citrate. The sections were exam-
ined by electron microscope.Preparation of whole-cell lysates
After treatment with Rott (0, 0.5, 1 and 2 μM), breast CSCs
were pelleted by centrifugation at 1,000 X rpm for 5 min
and washed once with PBS. Cells were then resuspended in
RIPA buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
1% v/v Nonidet P-40, 0.5% v/v sodium deoxycholate and
0.1% SDS) supplemented with protease inhibitor cocktail
(Sigma) and phosphatase inhibitor cocktail (Sigma), and
lysed on ice by sonicating for 5 s and 5–10 pulses. The ly-
sates were centrifuged for 20 min at 12,000 X g and super-
natant was collected and used for further experiments.
Western blot analysis
Total cellular lysates were obtained by lysing cells in a
buffer containing RIPA buffer and a mixture of protease
and phosphatase inhibitors. Lysates were sonicated for
5 s and 5–10 pulses, centrifuged for 20 min at 12,000 X
g and stored at -80°C. Equal amounts of lysate proteins
(50–60 μg total protein) were electrophoretically sepa-
rated by 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to nitrocel-
lulose membrane. Nitrocellulose blots were blocked with
5% nonfat dry milk in TBS buffer (20 mM Tris–HCl,
pH 7.4, and 500 mM NaCl), and incubated with primary
antibody in TBS-T (TBS and 0.01% Tween-20) overnight
at 4°C. Immunoblots were washed three times (5, 5 and
5 min each) with TBS-T followed by 1–2 h incubation
with secondary antibody. Chemiluminescence reactions
were carried out with the Super Signal West Pico sub-
strate (Thermo Fisher, Waltham, MA).
AutoDock-Vina docking file preparation and running
docking program
Ligands (Rott) were designed by using ACD/ChemS-
ketch Freeware software (http://www.acdlabs.com/re-
sources/freeware/chems- ketch/). Open Babel (An open
chemical toolbox) software used to convert 3D struc-
ture of ligand (.MOL file) into.PDB file. Ligands were
optimized by using Graphical User Interface program
AutoDockTools4 (ADT) [62]. Protein (C2-domain of
protein kinase C-delta) was downloaded from RCSB-
Protein Data Bank (PDB-ID: 1BDY) [49] and edited in.txt
file. Protein was optimized by using ADT [62]. Intermedi-
ary steps, such as.pdbqt files for protein and ligands prep-
aration and grid box creation were completed using ADT.
ADT assigned charges, solvation parameters and fragmen-
tal volumes to the protein. AutoDock saved the pre-
pared file in pdbqt format. AutoGrid was used for the
preparation of the grid map using a grid box. The grid
size was set to 58 × 56 × 74 xyz points with grid spacing
of 0.375 Å and grid center was designated at dimensions
(x, y, and z): -3.085, 28.517 and 37.651. AutoDock-Vina
was employed for docking using protein and ligand in-
formation along with grid box properties in the
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search global optimizer [50]. During the docking procedure,
both the protein and ligands are considered as rigid. The
results less than 1.0 Å in positional root-mean-square devi-
ation (RMSD) was clustered together and represented by
the result with the most favorable free energy of binding.
The pose with lowest energy of binding or binding affinity
was extracted and aligned with receptor structure for
further analysis.
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